DPP4 expression was assessed by qPCR in 22Rv1 and C4-2 cells treated with dasatinib or midostaurin at IC<sub>50</sub> concentrations.<h4>Results</h4>DPP4 exhibited tumor-specific dysregulation across multiple cancer types. The gene discussed is DPP4; the disease is neoplasm.